Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11427-11436

  Fouts, T R ^a   Tuskan, R ^a   Godfrey, K ^a   Reitz, M ^a   Hone, D ^a   Lewis, G K ^a   DeVico, A L ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; POLYPEPTIDE;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; BINDING SITE; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; VACCINATION; VIRUS REPLICATION;

AIDS VACCINES; ANTIGENS, CD4; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 0034467954     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11427-11436.2000     Document Type: Article

References (40)

1. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies
2. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
3. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
4. Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41
5. Antibody raised against soluble CD4-gp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding
6. HIV entry and its inhibition
7. A soluble form of CD4 (T4) protein inhibits AIDS virus infection
8. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates
9. HIV coreceptors and chemokines as therapeutic targets against HIV/AIDS
10. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp120
11. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product
12. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex
13. Envelope glycoproteins of HIV-1, HIV-2, and SIV purified with Galanthus nivalis agglutinin induce strong immune responses
14. New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
15. Codon usage limitation in the expression of HIV-1 envelope glycoprotein
16. Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein
17. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120
18. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
19. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
20. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV
21. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
22. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
23. Sensitive ELISA for the gp120 and gp160 surface glycoproteins of HIV-1
24. Use of vaccinia virus vectors for development of AIDS vaccines
25. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine
26. Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region
27. Introduction of eukaryotic expression cassettes into animal cells using a bacterial vector delivery system
28. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
29. Recent advances with recombinant bacterial vaccine vectors
30. HIV-1 entry inhibitors in the side pocket
31. Effect of major deletions in the Vi and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication
32. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization
33. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120
34. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
35. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
36. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses
37. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
38. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrahe glycoprotein
39. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
40. Characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions